Evidence map›Paper›PMID 20142810›Full record

ReviewNature reviews. Urology2010

New treatments for chronic prostatitis/chronic pelvic pain syndrome.

Adam C Strauss, Jordan D Dimitrakov

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Urology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00672087 (Diagnostic Challenges in IC), which is not on this map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00672087 completednot on this map

Diagnostic Challenges in IC (and Male CPPS)

TypeobservationalSponsorBeth Israel Deaconess Medical CenterRan2003 to 2011Enrolled1,000ConditionsChronic Prostatitis With Chronic Pelvic Pain Syndrome, Chronic Bacterial Prostatitis, Asymptomatic Inflammatory Prostatitis, Painful Bladder SyndromeArmsGenomic and proteomic biomarker discovery
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pregabalin for chronic prostatitis.The Cochrane database of systematic reviews · 2012
    Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Chronic Prostatitis and Pelvic Pain Syndrome: Another Autoimmune Disease?Archivum immunologiae et therapiae experimentalis · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Adam C StraussHarvard Medical School, Children's Hospital Boston, Enders Research Building, Room 1061, 300 Longwood Avenue, Boston, MA 02115, USA.
Jordan D Dimitrakov
Harvard University · US

Funding

Genetic Studies of Interstitial CystitisR01DK081647 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI DIMITRAKOFF, JORDAN D, KUNKEL, LOUIS M · 2008 to 2011
$2.3M
Diagnostic Challenges in IC (and Male CPPS)R01DK065990 · NIDDK · QUEEN'S UNIVERSITY AT KINGSTON · PI DIMITRAKOFF, JORDAN D · 2003 to 2007
$976k
LINKAGE ANALYSIS IN INTERSTITIAL CYSTITISR21DK070672 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI DIMITRAKOFF, JORDAN D · 2006 to 2007
$492k
NIDDK NIH HHS R01 DK065990NIDDK NIH HHS R01 DK081647NIDDK NIH HHS R21 DK070672
6 · The paper itself

Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition among men of a wide age range, with detrimental effects on quality of life. The etiology, pathogenesis, and optimal treatment of CP/CPPS remain unknown, although progress has been made in these domains in recent years. A wide variety of pharmacologic and nonpharmacologic therapies have been studied in clinical trials, but most have shown limited efficacy in symptom alleviation. CP/CPPS is increasingly viewed as a condition that involves variable degrees of neuropathic pain. Medications such as gabapentin, pregabalin, memantine, and tricyclic antidepressants are often used in other neuropathic pain conditions and, therefore, are considered potential treatments for CP/CPPS. Few studies of these agents in patients with CP/CPPS have been reported, but future clinical trials should help to determine their utility and to characterize the pathogenetic mechanisms of pain in CP/CPPS. Combining treatment trials with biomarker, genomic, and imaging studies, in addition to epidemiologic and symptom-based assessments, will maximize the ability to probe disease etiology and pathogenesis, as well as identify effective treatment.

Indexed as

AminesChronic DiseaseCognitive Behavioral TherapyCyclohexanecarboxylic AcidsGabapentingamma-Aminobutyric AcidHumansMalePelvic PainProstatitisRandomized Controlled Trials as TopicTreatment OutcomeAminesCyclohexanecarboxylic AcidsGabapentingamma-Aminobutyric Acid

Identifiers

PMID20142810
PMCPMC2837110
OpenAlexW2069548254

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.